WINTON GROUP Ltd

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1612063 LONDON, X0

Position in HALO

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$4,723,437

+$4,238,712 QoQ

Shares Held

60,348

+704.6% QoQ

Ownership

0.053%

of shares outstanding

% of Portfolio

0.16%

of 13F equity value

Holder Rank

#159

of 647 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

WINTON GROUP Ltd holds $97,029,578 across 91 Biotechnology names. HALO ranks #5 (4.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	254,408	$28,839,690
2	FTRE	Fortrea Holdings Inc.	389,155	$6,771,297
3	EXEL	Exelixis, Inc.	99,834	$5,431,967
4	TECH	BIO-TECHNE Corp	67,227	$4,749,587
5	HALO	Halozyme Therapeutics, Inc. This page	60,348	$4,723,437
6	VKTX	Viking Therapeutics, Inc.	90,546	$3,532,199
7	ALNY	Alnylam Pharmaceuticals, Inc.	7,880	$2,372,116
8	TRVI	Trevi Therapeutics, Inc.	106,852	$1,992,789

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,723,437	60,348	+704.6%	Shares	Sole	2026-08-07
2026-03-31	$484,725	7,500	+114.3%	Shares	Sole	2026-05-12
2025-09-30	$256,690	3,500	-97.6%	Shares	Sole	2025-11-13
2024-03-31	$6,025,928	148,130	+769.3%	Shares	Sole	2024-05-14
2023-03-31	$650,757	17,040	-86.4%	Shares	Sole	2023-05-12
2022-03-31	$4,979,775	124,869	-38.0%	Shares	Sole	2022-05-11
2021-12-31	$8,093,710	201,286	+379.5%	Shares	Sole	2022-02-10
2021-09-30	$1,707,827	41,982	-14.4%	Shares	Sole	2021-10-28
2021-06-30	$2,226,179	49,024	+6.3%	Shares	Sole	2021-08-10
2021-03-31	$1,923,368	46,135	-6.5%	Shares	Sole	2021-07-21
2020-12-31	$2,107,140	49,336	-75.6%	Shares	Sole	2021-02-12
2020-09-30	$5,311,214	202,101	+111.2%	Shares	Sole	2020-10-30
2020-06-30	$2,565,582	95,695	+12.7%	Shares	Sole	2020-08-05
2020-03-31	$1,527,045	84,883	—	Shares	Sole	2020-05-11
No filing history on record for this holder in this stock.